Search for: "Mutual Pharmaceutical Company, Inc."
Results 1 - 20
of 145
Sort by Relevance
|
Sort by Date
23 Jan 2024, 9:01 pm
Allianz Allianz Global’s $145 million payout benefits shareholders of collapsed mutual funds that Allianz managed. [read post]
20 Dec 2023, 2:50 pm
About Solutions Law Press, Inc. [read post]
19 Dec 2023, 4:48 pm
$115 is the fee that health plans participating in the Independent Dispute Resolution (“IDR”) process required by the No Surprises Act (the “NSA”) to resolve disputes with health care providers, facilities, and providers of air ambulance services (“providers”) over the amount the health plan will pay the provider for out-of-network health care or items for because the health plan and provider cannot reach agreement about the appropriate amount outside the IDR… [read post]
8 Dec 2023, 10:02 am
Health plans and other entities covered by the Health Insurance Portability and Accountability Act (“HIPAA”) should tighten their phishing deterrence and other safeguards in response to the announcement of the Department of Health and Human Services Office of Civil Rights (“OCR”) of its settlement of its first official phishing-related HIPAA charges with a Louisiana medical group subject to HIPAA as a health care provider. [read post]
10 Nov 2023, 1:35 pm
quickly to implement and communicate 2024 health spending account (“HFSA”), high deductible health plan amounts relevant to determining eligibility to contribute to a medical savings account (“MSA”), adoption credit and exclusion limits, and other inflation-adjusted limitations relevant to the annual enrollment, withholding and other year-end tax and benefit planning of workers and their families to assist workers to take into account these adjustments during 2024 benefit… [read post]
9 Nov 2023, 1:48 pm
Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. [read post]
9 Nov 2023, 1:07 pm
quickly to implement and communicate 2024 health spending account (“HFSA”), high deductible health plan amounts relevant to determining eligibility to contribute to a medical savings account (“MSA”), adoption credit and exclusion limits, and other inflation-adjusted limitations relevant to the annual enrollment, withholding and other year-end tax and benefit planning of workers and their families to assist workers to take into account these adjustments during 2024 benefit… [read post]
1 Nov 2023, 9:01 pm
In September 2023, Greek and Spanish authorities raided several companies involved in the sale of electricity distribution equipment. [read post]
7 Feb 2023, 12:00 pm
In response, several pharmaceutical companies, including Sanofi, sought to reinstate HHS’s earlier “one contract pharmacy per covered entity” policy by imposing it in their own rules for covered entities. [read post]
23 Jan 2023, 10:40 am
Our client was hired by State Mutual Insurance Company to provide accounting services for Dermatran. [read post]
8 Apr 2022, 2:05 am
(New York, NY) Corporate Counsel – Technology, Lowe’s Companies, Inc. [read post]
1 Feb 2022, 12:32 am
Regele dated 16 January 2017D50 Assignment by the inventors to Alexion Pharmaceuticals Inc. dated 28.03.2007, 02.04.2007 and 11.09.2007 respectivelyD51 Document supporting the name change from "UDEC Pharmaceuticals,Inc. to "Alexion Pharmaceuticals Inc"D52 Declaration of S. [read post]
21 Jan 2022, 2:17 pm
Hawbaker, Inc. [read post]
21 Jan 2022, 2:17 pm
Hawbaker, Inc. [read post]
14 Jan 2022, 2:47 pm
Wisconsin Judicare, Inc. [read post]
5 Jan 2022, 7:16 am
") A New Jersey federal judge backed a special master's order that Zhejiang Huahai Pharmaceutical Co. [read post]
30 May 2021, 8:57 pm
; Slaight Communications Inc. v. [read post]
13 May 2021, 2:24 pm
A company issues false or misleading statements, the truth emerges, and the company’s stock price drops causing investor losses. [read post]
16 Jan 2021, 10:57 pm
Companies use letters of intent as a versatile tool to meet the needs of their business transactions. [read post]
15 Jan 2021, 1:48 pm
Bausch Health (formerly Valeant Pharmaceuticals) – In yet another case of accounting fraud, the SEC obtained a $45 million penalty from Bausch Health, formerly known as Valeant Pharmaceuticals, to resolve charges that its executives engaged in improper revenue recognition and misleading disclosures in SEC filings and earnings presentations. [read post]
